Biorem Inc Stock Market Value
| BIRMF Stock | USD 1.75 0.00 0.00% |
| Symbol | BIOREM |
BIOREM 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BIOREM's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BIOREM.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in BIOREM on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding BIOREM Inc or generate 0.0% return on investment in BIOREM over 90 days. BIOREM is related to or competes with 374Water Common, California Nanotechnologies, Accord Financial, and Anaergia. BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control... More
BIOREM Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BIOREM's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BIOREM Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 32.17 | |||
| Information Ratio | 0.1164 | |||
| Maximum Drawdown | 1007.65 | |||
| Value At Risk | (7.64) | |||
| Potential Upside | 8.97 |
BIOREM Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIOREM's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BIOREM's standard deviation. In reality, there are many statistical measures that can use BIOREM historical prices to predict the future BIOREM's volatility.| Risk Adjusted Performance | 0.1195 | |||
| Jensen Alpha | 17.46 | |||
| Total Risk Alpha | (3.66) | |||
| Sortino Ratio | 0.4667 | |||
| Treynor Ratio | (0.89) |
BIOREM Inc Backtested Returns
BIOREM is out of control given 3 months investment horizon. BIOREM Inc secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of risk over the last 3 months. We have collected data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 15.16% are justified by taking the suggested risk. Use BIOREM mean deviation of 32.63, and Risk Adjusted Performance of 0.1195 to evaluate company specific risk that cannot be diversified away. BIOREM holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -16.99, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning BIOREM are expected to decrease by larger amounts. On the other hand, during market turmoil, BIOREM is expected to outperform it. Use BIOREM potential upside, and the relationship between the sortino ratio and skewness , to analyze future returns on BIOREM.
Auto-correlation | 0.10 |
Insignificant predictability
BIOREM Inc has insignificant predictability. Overlapping area represents the amount of predictability between BIOREM time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BIOREM Inc price movement. The serial correlation of 0.1 indicates that less than 10.0% of current BIOREM price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | 0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
BIOREM Inc lagged returns against current returns
Autocorrelation, which is BIOREM pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BIOREM's pink sheet expected returns. We can calculate the autocorrelation of BIOREM returns to help us make a trade decision. For example, suppose you find that BIOREM has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BIOREM regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BIOREM pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BIOREM pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BIOREM pink sheet over time.
Current vs Lagged Prices |
| Timeline |
BIOREM Lagged Returns
When evaluating BIOREM's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BIOREM pink sheet have on its future price. BIOREM autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BIOREM autocorrelation shows the relationship between BIOREM pink sheet current value and its past values and can show if there is a momentum factor associated with investing in BIOREM Inc.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in BIOREM Pink Sheet
BIOREM financial ratios help investors to determine whether BIOREM Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOREM with respect to the benefits of owning BIOREM security.